Rigel Pharma (RIGL) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.87 +1.66%
EPS Growth %: -34.9%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -34.9%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $11.37 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
- AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
